Screener
Olema Pharmaceuticals, Inc. OLMA Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $49.23M+60.8% | $43.22M+33.8% | $39.95M+20.2% | $43.9M+50.8% | $30.62M+2.5% | ||
| $8.75M+106% | $6.86M+53.6% | $5.93M+34.8% | $3.96M-10.4% | $4.25M-4.6% | ||
| $57.99M+66.3% | $50.08M+36.2% | $45.88M+21.9% | $47.86M+42.7% | $34.87M+1.6% | ||
| -$57.99M-66.3% | -$50.08M-36.2% | -$45.88M-21.9% | -$47.86M-42.7% | -$34.87M-1.6% | ||
| $4.9M+9.2% | $4.02M+25.7% | $3.66M+19.4% | $4.08M+29.6% | $4.48M+33.1% | ||
| -$53.09M-74.7% | -$46.06M-37.2% | -$42.22M-22.2% | -$43.78M-44.1% | -$30.39M+1.9% | ||
| -$0.52-44.4% | -$0.51-27.5% | -$0.49+18.3% | -$0.51+5.6% | -$0.36+35.7% | ||
| -$57.87M-66.5% | -$49.9M-36.1% | -$45.83M-22.1% | -$47.73M-42.8% | -$34.75M-1.4% | ||
| -$57.99M-66.3% | -$50.08M-36.2% | -$45.88M-21.9% | -$47.86M-42.7% | -$34.87M-1.6% |
FAQ
- Is Olema Pharmaceuticals, Inc. profitable?
- Olema Pharmaceuticals, Inc. is not currently profitable: it reported a net loss of $185.2M over the trailing twelve months.
- What is Olema Pharmaceuticals, Inc.'s earnings per share?
- Olema Pharmaceuticals, Inc.'s diluted EPS over the trailing twelve months is $-2.03.
- Where does Olema Pharmaceuticals, Inc.'s income statement data come from?
- Every line is extracted from Olema Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.